Defense World
04 Jan 2026, 06:55 UTC · 38w ago
Verdict
Headline takes no side. We score CATX +0.80 across one claim — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
Perspective Therapeutics (CATX) holds a consensus 'Buy' rating from ten covering brokerages, with 100% of analysts rating it as either 'Buy' or 'Strong Buy'.
More positive than 79% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 88% of ticker scores this week
The company has received a consensus 'Buy' rating with strong buy ratings from several analysts.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
5h ago
−1.1%
Price is moving against the score
$2.76 vs $2.79 close before publication (Jan 2) · not market-adjusted
CATX chart →
